Dear Editor,I read with interest the article on “‘Can the postoperative follow-up visit be deferred up to four weeks after an uneventful cataract surgery? A randomized controlled trial”’ by Deshpande et al.[1]In this study methodology, few important questions remain unanswered. The study does not mention the postoperative medical regimen for the patients undergoing cataract surgery. Which topical steroid was given in the postoperative period? Was the medical management uniform for all the patients? How were the topical steroids tapered in the postoperative period?Results section mentions that 1/212 patient undergoing phacoemulsification had elevated intraocular pressure (IOP) of 36 mm of Hg and 2/212 patients undergoing manual small incision cataract surgery showed the presence of active, moderate anterior chamber inflammation. At what postoperative time period, was this noted?The authors conclude that the risk of inadvertent complications exist in spite of an uneventful cataract surgery, but they generate their own symptoms in the form of pain, redness, photophobia, or diminution of vision, which would result in the patient approaching the hospital voluntarily. I do not agree with the authors as some of the most significant early complications like IOP spike can be asymptomatic and will remain undetected unless the patient is routinely reviewed, as per the recommended postoperative follow-up visit schedule by National Programme of Control of Blindness, Vision 2020: Right to Sight.If the ophthalmologist decides to discontinue the 1-week follow-up appointment after an uneventful cataract surgery, some asymptomatic patients may have undetected complication and, however, low the risk may be, it is unacceptable.[2]